Is there any difference between the third generation test tubes in Kyrgyz Tulip International Reproductive Center? Make it clear in five dimensions

First, let's be clear: the third generation test tube is not a "fixed project"

Many people search for "Is there a difference between the third generation test tubes of the Kyrgyz Tulip International Reproductive Center?" What I really want to ask is not the difference in name, but: It is also called the third generation test tube. Why do some people do chromosome screening, some people do genetic disease testing, and some people need both husband and wife to do genetic analysis first?

From the medical concept, the third generation test tube usually corresponds to the genetic test before embryo implantation, which is PGT. It is not a single technology, but a set of detection paths. Common ones include PGT-A, PGT-M and pgt-Sr. The ASRM Committee's opinion in 2024 also pointed out that the value of PGT-A as a routine screening for all IVF population has not been proved, and whether to use it needs to be judged according to individual conditions.

In other words, the core of the third generation of test tubes is not "whether to do it or not", but "why to do it, what to test, and how to use the test results for transplant decision".

Experts suggest that the third generation of test tubes can help doctors get more information about embryo genetics, but they cannot replace factors such as age, ovarian function, sperm quality, uterine environment and transplant management. In medicine, more emphasis is placed on the matching of indications, rather than equating technical names with results.

Second, what is the technical difference? The key is to look at these three types of tests.

It is also a three-generation test tube, and the difference is mainly reflected in the detection target.

1. PGT-A: Mainly depends on the number of embryo chromosomes.

PGT-A is mainly used to detect whether there is chromosome aneuploidy in embryos, such as one more chromosome and one less chromosome. Clinically, it is common in people with advanced age, repeated implantation failure, repeated abortion and high risk of chromosome abnormality in previous embryos.

However, it should be noted that not everyone has to do PGT-A. It is clearly mentioned in the ASRM document that PGT-A is a universal screening method for all IVF patients, and its value has not been fully proved.

Therefore, if the age is young, the number of embryos is small, and there is no clear genetic risk, whether to do PGT-A needs careful evaluation.

2. PGT-M: Mainly aimed at single-gene genetic diseases.

PGT-M is more inclined to "family genetic disease risk management". If one or both husband and wife carry a definite risk of monogenic diseases, such as some hereditary hematological diseases, neuromuscular diseases, metabolic diseases, etc., doctors usually suggest genetic counseling first, and then judge whether it is necessary to establish a testing program.

The ASRM Ethics Committee's opinion on PGT-M points out that PGT-M for adult-onset monogenic diseases is ethically acceptable in many cases, and it is strongly recommended that genetic counselors who are familiar with genetics and assisted reproduction participate in the consultation.

This shows that PGT-M is not simply "screening embryos", but should first confirm the family genetic background, pathogenic site, detection scheme and available embryos.

3. PGT-SR: Mainly aimed at chromosomal structural abnormalities.

If one of the husband and wife has abnormal chromosome structure such as balanced translocation, Roche translocation and inversion, it may affect the chromosome balance of the embryo. The significance of PGT-SR is to help identify whether the chromosome structure is relatively balanced and reduce the risk of partial abortion or repeated failure.

This kind of population is usually not as simple as "trying to improve the success rate", but there is a clear risk of chromosome structure, which needs to be combined with karyotype analysis report and genetic counseling and judgment.

Expert tip: the essence of the difference between the three generations of test tubes is that the test objects are different. PGT-A looks at chromosome number, PGT-M looks at single gene genetic risk, and PGT-SR looks at chromosome structural abnormality. Different tests cannot be confused.

Third, who needs to focus on the differences between the three generations of test tubes?

From the clinical logic, the following groups of people are more likely to be involved in the differences of three generations of test tube schemes.

1. People who are older and worried about abnormal embryo chromosomes.

As women get older, the proportion of abnormal chromosomes in oocytes usually increases, and the risk of embryo aneuploidy also increases. According to CDC data, the average age of American ART population is 36.3 years old, and the proportion of live births in ART cycle is 37.5%. These data also suggest that age is closely related to the evaluation of assisted reproductive outcomes.

But this does not mean that older people must be suitable for a certain fixed scheme. Doctors usually also look at indicators such as AMH, basal follicle number, number of eggs taken in the past, embryo formation and blastocyst number.

2. Repeated abortion or repeated transplantation is unsuccessful.

If the ideal results are still not obtained after many transplants, the doctor may investigate from embryo factors, intimal factors, immune and coagulation factors, intrauterine environment, endocrine status and other directions. The third generation test tube is just one of the analysis tools, which does not mean that all problems come from embryonic chromosomes.

3. One of the spouses is at risk of chromosomal abnormality or genetic disease.

This kind of people need to distinguish between PGT-M and PGT-SR, instead of just asking "can the third generation do it?". If there is a clear family history of genetic diseases, it is usually recommended to do genetic counseling and genetic testing before deciding on the embryo testing plan.

4. People who want to go to Kyrgyzstan to receive assisted reproductive services

For people who are concerned about the international reproductive center of Tulip in Kyrgyzstan, more realistic problems include: whether there are medical indications suitable for them, whether the preliminary examination can be completed in China, how to arrange the cycle of going to Kyrgyzstan, how to link the cycle of embryo culture and testing, how to interpret the report, and whether it is necessary to adjust the endometrium before transplantation.

This kind of problem is more important than simply comparing the "first generation technology".

Fourth, what is the difference in the process? The third generation test tubes usually have more detection and waiting links.

The general process of the third generation test tube can be divided into several stages: pre-evaluation, ovulatory retrieval, in vitro fertilization, embryo culture, embryo biopsy, genetic testing, result interpretation and transplantation arrangement.

Compared with conventional test tubes, the third generation test tubes usually have two more key nodes:

1. Embryo biopsy

After embryos are usually cultured to blastocyst stage, a small number of cells are biopsied in the laboratory and then sent for genetic analysis. This link requires laboratory operation, embryo quality and testing scheme.

2. Waiting for test results

After the test results come out, the doctor will arrange follow-up transplantation in combination with embryo grade, genetic results, patient age, endometrial status and other factors. Some people may be suitable for frozen embryo transfer, while others need to deal with uterine cavity, endometrium or endocrine problems first.

Summary box: the third generation test tube process is not a simple path of "transplanting immediately after taking eggs" It is more like a medical decision-making process of "obtaining embryos first, then analyzing embryos, and then deciding the order of transplantation".

V. Frequently Asked Questions: Some questions that customers really care about.

Q: Is there any difference between the third generation of test tubes in Kyrgyz Tulip International Reproductive Center?

There are differences. The differences are mainly in detection purposes: PGT-A is biased towards chromosome number screening, PGT-M is biased towards single-gene genetic disease detection, and PGT-SR is biased towards chromosome structural abnormality analysis. The specific choice of which scheme should be decided according to the results of husband and wife examination and doctor's evaluation.

Q: Is it easier to succeed by making three generations of test tubes?

Can't understand it like this. The third generation of test tubes can help screen some embryos with low genetic risk, but it does not mean commitment to pregnancy or live birth. Asrm's view in 2024 also reminds that PGT-A should not be simply understood as a routine screening suitable for all IVF people.

Q: Are all the elderly people suitable for the third generation of test tubes?

Older people need to pay more attention to the risk of embryo chromosomes, but whether it is suitable for the third generation of test tubes depends on ovarian reserve, the number of embryos available, past failure history and physical condition. If the number of embryos is small, whether to biopsy or wait for the test results needs to be comprehensively judged by doctors.

Q: Can the third generation test tubes screen all diseases?

I can't. PGT focuses on specific genetic problems and cannot cover all birth defects, developmental problems or pregnancy risks. Even if the embryo test results are ideal, prenatal examination, prenatal screening and prenatal diagnosis are still of medical significance.

Q: What should I prepare for the third generation test tube in Kyrgyzstan?

It is usually recommended to prepare basic examinations for both husband and wife, including reproductive hormones, AMH, Yin Chao, semen analysis, infectious disease screening, chromosome karyotype, and related tests for genetic diseases if necessary. If you have a history of abortion, genetic disease or repeated failure, you should also prepare previous medical records, embryo reports, transplant records and abortion tissue test reports.

Conclusion: The difference of three generations of test tubes is essentially the difference of medical indications.

Back to the core question: Is there any difference between the third generation of test tubes in Kyrgyz Tulip International Reproductive Center? The answer is that there is a difference, and the difference is not only the price or name, but also the difference in the detection object, the applicable population, the process cycle and the medical decision-making method.

For people who are going to Kyrgyzstan for assisted reproduction, it is suggested that they should not only ask "can they do three generations", but should focus on four things:

First, whether you have clear medical indications;

Second, it is suitable for PGT-A, PGT-M or PGT-SR；;

Third, whether the number of embryos supports testing;

The fourth is how to connect the test results with the transplantation scheme.

From the trend of assisted reproductive content in 2026, user search pays more attention to "cost, process, suitable population, success factors, risk boundary and how to choose a hospital". Therefore, rationally judging the differences between the three generations of test tubes is a way closer to the real medical decision.